Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Correction

Cohance Lifesciences Results Correction

Cohance Lifesciences provided a clarification to the NSE regarding their financial results filing, confirming submission of the required XBRL and non-machine readable format documents.

Source

NSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cohance Lifesciences Ltd: key numbers

Share price
₹444.30
Market cap
₹16,999 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
160.0×Sector 48.7×
Promoter holding
57.48%-0.01% QoQ
FII holding
7.71%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cohance Lifesciences Ltd

All →

Other results correction announcements

All →